New oral anticoagulants for the treatment of acute venous thromboembolism: are they safer than vitamin K antagonists? A meta-analysis of the interventional trials

Direct oral anticoagulants in the treatment of acute venous thromboembolism: A systematic review and meta-analysis

(2014) Antonio Gómez-Outes et al.   THROMBOSIS RESEARCH

Meta-Analysis of Rivaroxaban and Bleeding Risk

(2013) Guila Wasserlauf et al.   AMERICAN JOURNAL OF CARDIOLOGY

Meta-Analysis of Randomized Controlled Trials on Risk of Myocardial Infarction from the Use of Oral Direct Thrombin Inhibitors

(2013) Ramin Artang et al.   AMERICAN JOURNAL OF CARDIOLOGY

Interventional trials with anticoagulants in acutely ill medical patients: a methodological pitfall?

(2013) Francesco Violi et al.   Internal and Emergency Medicine

Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis

(2013) T. van der Hulle et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

(2013) Christian T Ruff et al.   LANCET

Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism

(2013)   NEW ENGLAND JOURNAL OF MEDICINE

Oral Apixaban for the Treatment of Acute Venous Thromboembolism

(2013) Giancarlo Agnelli et al.   NEW ENGLAND JOURNAL OF MEDICINE

Should all acutely ill medical patients be treated with antithrombotic drugs?

(2013) Ludovica Perri et al.   THROMBOSIS AND HAEMOSTASIS

Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants (Dabigatran, Rivaroxaban, Apixaban) Versus Warfarin in Patients With Atrial Fibrillation

(2012) Corey S. Miller et al.   AMERICAN JOURNAL OF CARDIOLOGY

Dabigatran Association With Higher Risk of Acute Coronary Events

(2012) Ken Uchino   ARCHIVES OF INTERNAL MEDICINE

Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control

(2012) Allan C. Skanes et al.   CANADIAN JOURNAL OF CARDIOLOGY

Bleeding of New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials

(2012) Joey S. W. Kwong et al.   CARDIOVASCULAR DRUGS AND THERAPY

Oral Anticoagulant Therapy

(2012) Walter Ageno et al.   CHEST

Prevention of VTE in Nonsurgical Patients

(2012) Susan R. Kahn et al.   CHEST

Approach to Outcome Measurement in the Prevention of Thrombosis in Surgical and Medical Patients

(2012) Gordon H. Guyatt et al.   CHEST

Systematic Review and Adjusted Indirect Comparison Meta-Analysis of Oral Anticoagulants in Atrial Fibrillation

(2012) William L. Baker et al.  

Pulmonary embolism and deep vein thrombosis

(2012) Samuel Z Goldhaber et al.   LANCET

Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials

(2012) B. D. Fox et al.   BMJ-British Medical Journal

Old Versus New Oral Anticoagulants: Focus on Pharmacology

(2011) Jawed Fareed et al.   Annual Review of Pharmacology and Toxicology

Role of Tissue Factor in Venous Thrombosis

(2011) David A. Manly et al.   Annual Review of Physiology

Oral Rivaroxaban for Symptomatic Venous Thromboembolism

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

(2009) Sam Schulman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE